MPMichail Yu. Pikunov

Michail Yu. Pikunov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Michail Yu. Pikunov has a total of 35 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Features of surgical treatment of a patient with ACTH-ectopic syndrome of pulmonary localization in combination with HIV infection

    by M. Yu. Pikunov, A. A. Pechetov, I. I. Danilov, D. A. Kabanova

    This clinical case demonstrates the feasibility of successful surgical treatment for a patient with severe ACTH-ectopic syndrome complicated by HIV infection. Understanding the specific characteristics of HIV infection in cancer patients allowed us to effectively perform surgery, predict the severity of the postoperative period and, consequently, implement appropriate preventive measures for successful cure of the patient.

  • Open Access

    The choice of therapeutic tactics in a patient with diagnosed breast cancer and lung neoplasm

    by N. Yu. Germanovich, M. Yu. Pikunov, T. A. Shchegolkova, I. M. Mishchenko

    Breast cancer (BC) has long held a leading position in oncology disease pattern among global female population. Statistics data show that BC metastasis to lung tissue accounts for 21–32 % of all distant metastasis cases. Pulmonary metastases usually occur within 5 years after initial BC diagnosis, more often affecting peripheral lung parts, which explains the difficulty for their differential diagnosis. In addition, they profoundly impact on disease course and patient survival rate, so that each case of combined pathology such as BC and lung solid neoplasm is of interest in terms of clinicopathologic features as well as the diagnostic approach, with subsequent choice of surgical treatment tactics. Obviously, a therapeutic strategy in such cases is based on knowing primary tumor morphological structure and verifying metastatic process. However, in case of small sized pulmonary focus, it is difficult to identify a modality of ongoing process. Currently, no therapeutic and diagnostic tactics in such cases have been developed in detail. Assessing the clinical case of a combined ВС and a single small-sized focal lung mass, we propose an effective diagnostics and treatment scheme.


  • Open Access

    Ectopic acromegaly due to bronchial neuroendocrine tumors: the first description in Russia of three clinical cases

    by E. O. Mamedova, E. G. Przhiyalkovskaya, S. A. Buryakina, E. V. Bondarenko, A. M. Lapshina, M. Yu. Pikunov, Zh. E. Belaya, G. A. Melnichenko

    Эктопическая акромегалия вследствие нейроэндокринных опухолей легких: первое описание в России трех клинических случаев


  • Open Access

    CT features of pulmonary ACTH-Secreting Tumor

    by S. A. Buryakina, M. Yu. Pikunov, N. V. Tarbaeva, Zh. E. Belaya, Г. Г. Кармазановский, N. G. Mokrysheva

    The purpose of the study is to improve the accuracy of CT diagnostics of pulmonary ACTH-Secreting Tumor. Material and methods. During the period from 2010 to 2022 at the Endocrinology Research Centre and the National Medical Research Center of Surgery named after A. Vishnevsky of the Ministry of Health of Russia 23 patients with pulmonary ACTH-Secreting Tumor were examined and treated. CT-features were analyzed: localization, shape, contours, connection of the formation with the bronchus, connection of the formation with the vessel, adherence to the vessel and bronchus along the long axis, structure of the neoplasm. We also analyzed the largest size of the formation, the size of the largest regional lymph node, the density of the tumor on axial sections in the native, arterial, venous and delayed phases of the study. Results. In the study, we identified a new phenotypic CT sign – the relationship with the bronchovascular bundle. The connection with the bronchus and vessel was assessed in detail. In the majority of patients, the connection with the pulmonary vessels (in most cases with small bronchial arteries) was especially clearly noted: an intimate attachment of the tumor along its long axis to the vessel. Less often it was possible to trace the connection with the bronchus. Conclusion. ACTH-producing NET of the lung is most often a peripherally located oval-shaped formation with even/ lobulated contours, adjacent to the bronchovascular bundle along the long axis of the tumor, intensively enchancing (increase of density parameters by more than 40 HU compared with the unenhanced phase) in the venous, less often the arterial phase of bolus contrast enhancement.

  • Open Access

    Survival predictors in patients with ectopic acth syndrome

    by O O Golounina, Zh/ E Belaya, L Ya Rozhinskaya, M Yu Pikunov, A A Markovich, L K Dzeranova, E I Marova, N S Kuznetsov, V V Fadeev, G A Melnichenko, et al.

    AIM: To determine significant factors affecting the survival of patients with ectopic ACTH syndrome (EAS).MATERIALS AND METHODS: A multi-center, observational study with a retrospective analysis of patients with EAS. The end point of the study was the fatal outcome of patients from various causes. In order to identify predictors of survival or mortality, univariate and multifactorial Cox regression analyses were carried out. ROC-analysis was used to determine the prognostic threshold values of individual predictors. The survival analysis was carried out using the Kaplan-Mayer method. Statistical data processing was carried out by using IBM SPSS Statistics 23.RESULTS: The age of patients at the time of diagnosis ranged from 12 to 76 years (Me 40 years [28;54]). The age of the studied population was 55 years [38; 64] for women and 42 years [32; 54] for men. The median period of observation was 50 months [13;91], with a maximum follow-up of 382 months. 92 patients (60,9%) had bronchopulmonary NET, 17 (11,3%) — thymic carcinoid, 8 — pancreatic NET, 5 –pheochromocytoma, 1– cecum NET, 1– appendix carcinoid tumor, 1 — medullary thyroid cancer and 26 (17,2%) patients had an occult NET. The primary tumor was removed in 101 patients (66,9%). Bilateral adrenalectomy was performed in 42 (27,8%) cases. Metastases were revealed in 23,2% (n=35) of patients. Relapse of the disease was observed in 24,4%, long-term remission was preserved in 64 patients (74,4%). Death occurred in 42 patients (28%). The average age of survivors was 47,0±15,2 versus 53,5±15,6 years for the deceased (p=0,022). The average survival time from diagnosis for the deceased was 32 months, Me 16,5 months [7;54]. Multivariate analysis revealed that the following factors have a direct impact on survival: age of diagnosis ≥51 years (OR 4,493; 95% CI 2,056–9,818, pCONCLUSION: The prognosis of patients with EAS is influenced by the age of diagnosis, NET localization, distant metastases and level of LNSC. The most common cause of ectopic ACTH syndrome was bronchopulmonary NET which was associated with the best survival rate.


  • Open Access

    Features of preparation and surgical aspects of treatment of patients with ACTH-producing neuroendocrine lung tumors

    by M. Yu. Pikunov, A. A. Pechetov, O. O. Golounina, S. A. Buryakina, L. Ya. Rozhinskaya, Zh. E. Belaya, Л. Я. Рожинская

    BACKGROUND: The Department of Thoracic Surgery of the National Medical Research Center of Surgery named after A. V. Vishnevsky has been dealing with the problem of surgical treatment of patients with neuroendocrine lung tumors for more than 20 years. This article presents the experience of treating patients with ectopic ACTH syndrome over the past 15 years.AIM: To study the features of preparation, surgical aspects of treatment and delayed results in patients with ACTH-producing tumors of bronchopulmonary localization.MATERIALS AND METHODS: The study included 55 patients who underwent surgical treatment of ACTH-producing neuroendocrine tumor of bronchopulmonary localization in the period from 2005 to 2020. In order to systematize the approach to surgical treatment and the choice of the type of operation, a point analysis of the patient’s severity has been developed. Demographic information about patients, anamnesis data, results of hormonal and instrumental studies at pre- and postoperative stages and long-term treatment results were analyzed. The control period of observation of patients after surgery ranged from 6 months to 5 years.RESULTS: The age of the patients ranged from 18 to 72 years (36±15). According to the MSCT results of the chest, neoplasms in the lungs ranging in size from 5 to 25 mm were detected. Patients who scored from 18 to 23 points had lung resection due to the severity of the condition. With a total score from 14 to 18, segmentectomy with lymph node dissection was performed. When the total score was less than 14, a lobectomy with lymph node dissection was performed. During the planned histological examination, lung neuroendocrine tumor of various differentiation degree was confirmed in all patients. The results of treatment were followed in the period from 6 to 60 months, with a median of 19 months [10;24]. Regression of clinical manifestations of hypercortisolism after 1 year of dynamic follow-up period was detected in 83% of patients. After 60 months of follow-up 10 patients (71.4%) had a persistent clinical effect after surgical treatment with complete regression of hypercortisolism symptoms.CONCLUSION: The analysis of the results of surgical treatment, according to the proposed methodological aspects, with dynamic control after 6, 12 and 36 months showed the effectiveness of such surgical intervention with results comparable to the world indicators of leading clinics.


  • Open Access

    Clinical and laboratory characteristics and results of treatment of patients with ACTH-producing neuroendocrine tumors of various localization

    by Olga O. Golounina, Zhanna E. Belaya, Liudmila Ya. Rozhinskaya, Evgeniya I. Marova, Michail Yu. Pikunov, Patimat M. Khandaeva, Svetlana D. Arapova, Larisa K. Dzeranova, Nikolai S. Kuznetsov, Valentin V. Fadeev, et al.

    Aim. To study the clinical, biochemical characteristics, treatment results and follow-up of patients with ectopic ACTH syndrome EAS (ACTH adrenocorticotropic hormone ). Materials and methods. A retrospective, observational, single-center study of 130 patients with EAS. Demographic information of patients, medical history, results of laboratory and instrumental investigations at the pre- and postoperative stages and follow-up of EAS were analyzed. Results. The mean age at the diagnosis ranged from 12 to 74 years (Me 40 years [28; 54]). The duration of the disease from the onset of symptoms to the verification of the diagnosis varied from 2 to 168 months (Me 17.5 months [7; 46]). Eighty-one (62,3%) patients had bronchopulmonary NET, 9 thymic carcinoid, 7 pancreatic NET, 5 pheochromocytoma, 1 cecum NET, 1 appendix carcinoid tumor, 1 medullary thyroid cancer and 25 (19.2%) had an occult source of ACTH. The median follow-up period of patients was 27 months [9.75; 61.0] with a maximum follow-up of 372 months. Currently, primary tumor was removed in 82 (63.1%) patients, bilateral adrenalectomy was performed in 23 (18%) patients, in 16 of them there was an occult source of ACTH-producing NET and in 7 patients in order to control hypercortisolism after non-successful surgical treatment. Regional and distant metastases were revealed in 25 (19.2%) patients. At the time of the last observation 59 (72%) patients were exhibited a full recovery, 12 (14.6%) had relapse of the disease and 26 (20%) died from multiple organ failure (n=18), pulmonary embolism (n=4), surgical complications (n=2), disseminated intravascular coagulation syndrome (n=1) or COVID-19 (n=1). Conclusion. In our cohort of patients bronchopulmonary NET are the most frequent cause of EAS (62.3%). Surgical treatment leads to remission of hypercortisolism in 72% cases; the proportion of relapse (14.6%) and fatal outcome (20%) remains frequent in EAS.


  • Open Access

    Surgical treatment for the patient with the neuroendocrine lung tumor associated with ectopic ACTH-secretion syndrome: case report

    by Michail Y. Pikunov, Alexey A. Pechetov, Yury S. Esakov, Alexey N. Lednev

    Among primary neoplasms of the lungs, the proportion of neuroendocrine tumors is up to 20–25%. According to the Surveillance Epidemiology and Results (SEER) database, since 1970 there has been a significant increase in primary carcinoid tumors of various organs with the highest incidence of morbidity in the broncho-pulmonary localization group. Carcinoid tumors of the lung level are approximately 2% of all primary lung tumors, but only 5% of these formations are associated with ACTH production. Despite the severity of clinical manifestations and the acceleration of hypercorticoid processes, the topical diagnosis of ACTH-ectopic syndrome often causes certain difficulties. The difficulty in diagnosing ectopic tumors is due to the fact that most of these formations are so small that they can be missed by standard methods of examination (X-ray, ultrasound, MSCT or MRI). After the diagnosis of ACTH-ectopic syndrome is completely optimal method of pathogenetic therapy is a radical removal of the tumor, which leads to the normalization of the functions of the adrenal cortex and the elimination of hypercorticoidism. However, the achievement of this goal in many cases is difficult due to late topical diagnosis, the prevalence of the tumor process and extensive metastasis. There is a clinical observation of a patient with a diagnosis of a neuroendocrine lung tumor with ACTH-ectopic syndrome. The importance of the multidisciplinary approach, the methods of differential diagnosis, the features of the perioperative period and the long-term results of treatment are described.


  • Open Access

    Pulmonary epithelioid hemangioepithelioma

    by K. A. Pavlov, E. A. Dubova, A. I. Shchegolev, M. Yu. Pikunov

    Эпителиоидная гемангиоэндотелиома легких